sb 203580 has been researched along with Silicosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Di, L; Guoliang, A; Li, C; Lin, T; Piye, N; Xiaoli, L; Ximeng, L; Yan, W; Zhonghui, Z | 1 |
1 other study(ies) available for sb 203580 and Silicosis
| Article | Year |
|---|---|
SB203580 inhibits epithelial-mesenchymal transition and pulmonary fibrosis in a rat silicosis model.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Epithelial-Mesenchymal Transition; Imidazoles; Male; p38 Mitogen-Activated Protein Kinases; Pulmonary Fibrosis; Pyridines; Rats; Rats, Wistar; Signal Transduction; Silicon Dioxide; Silicosis | 2016 |